Tower Research Capital LLC (TRC) - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 1 filers reported holding CATALYST BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,936
+328.3%
4,017
+212.6%
0.00%
Q2 2023$4521,285
-6.7%
0.00%
Q1 2023$0
-100.0%
1,377
-1.2%
0.00%
Q4 2022$1
-99.9%
1,394
-32.9%
0.00%
Q3 2022$1,000
-50.0%
2,076
+75.3%
0.00%
Q2 2022$2,0000.0%1,184
-62.7%
0.00%
Q1 2022$2,000
-85.7%
3,175
+15.5%
0.00%
Q1 2021$14,0000.0%2,748
+22.8%
0.00%
Q4 2020$14,000
-82.3%
2,238
-87.8%
0.00%
-100.0%
Q3 2020$79,000
+19.7%
18,326
+61.9%
0.00%
-66.7%
Q2 2020$66,000
+725.0%
11,322
+585.8%
0.00%
Q1 2020$8,000
-55.6%
1,651
-38.6%
0.00%
-100.0%
Q4 2019$18,0002,688
+3062.4%
0.00%
Q3 2019$0
-100.0%
85
-97.9%
0.00%
-100.0%
Q2 2019$29,000
+2800.0%
4,037
+2288.8%
0.00%
Q1 2019$1,000
-90.0%
169
-81.8%
0.00%
-100.0%
Q3 2018$10,000
+150.0%
931
+148.9%
0.00%
Q2 2018$4,0003740.00%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q4 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 547,541$3,214,0006.22%
ACUTA CAPITAL PARTNERS, LLC 1,497,900$8,793,0002.54%
22NW, LP 735,841$4,319,0002.34%
Prosight Management, LP 248,050$1,456,0000.62%
Worth Venture Partners, LLC 127,983$751,0000.37%
Parkman Healthcare Partners LLC 215,237$1,263,0000.36%
Sio Capital Management, LLC 198,714$1,166,0000.34%
Amtrust Financial Services, Inc. 50,000$294,0000.32%
Nantahala Capital Management 1,821,749$10,694,0000.32%
Essex Woodlands Management, Inc. 78,622$462,0000.23%
View complete list of CATALYST BIOSCIENCES INC shareholders